English | Español

Bristol-Myers Squibb
Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
Robert Hadley | May 14, 2017

Partnership to launch study of two drugs, chemotherapy to treat lung cancer
Chandra Lye | May 11, 2017

Opdivo given European approval for patients with head and neck squamous cell cancer
Robert Hadley | Apr 14, 2017

FDA to speed Opdivo review for use as colorectal cancer drug
Robert Hadley | Apr 10, 2017

Bristol-Myers Squibb to contunue testing Opdivo for brain tumors
Robert Hadley | Apr 7, 2017

Early tests show Opdivo triples life expectancy in lung-cancer patients
Kyle Perrotti | Apr 6, 2017

Parker Institute, Cancer Research Institute join forces for project
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project

Trending
Patient Daily | Aug 12, 2025

Capitol Breathe Free Otolaryngologist on air quality and pollution: ‘These are common triggers for sinus inflammation and sinus infections’
+ Regulatory
Patient Daily | Aug 14, 2025

Founder of Policy Candy: '340B must see comprehensive reforms'
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+ Pharmaceuticals
Patient Daily | Aug 14, 2025

PhRMA COO on 340B: 'Hidden tax on patients, taxpayers & employers'